Direct oral anticoagulants (DOACs) in MPN thrombosis
Current understanding
To be populated as evidence accumulates.
Evidence log
Open questions
Related
Contributing findings
Managing thrombotic risk in myeloproliferative disorders.
12-sep-2026
novelty 1
per-area 2
mentions